Literature DB >> 32990105

Challenges of acute phase neuroimaging in VA-ECMO, pitfalls and alternative imaging options.

Hassan Aboul Nour1, Neo Poyiadji2, Ghada Mohamed1, Owais K Alsrouji1, Ahmad-Riad Ramadan1, Brent Griffith2, Horia Marin2, Alex Bou Chebl1.   

Abstract

Large vessel occlusion in patients on ECMO is challenging to appreciate clinically secondary to sedation or induced paralysis, thus placing more emphasis on neurovascular imaging. However, emergent CTA and CTP are both inaccurate and unreliable in ECMO patients due to altered circuitry and interference with normal physiologic hemodynamics. In this review, the utility of DSA is discussed in evaluating the altered hemodynamics of VA-ECMO circuits and patency of major vasculature. In addition, the potential use of TCD in ECMO patients is discussed.

Entities:  

Keywords:  ECMO; Stroke; angiography; neuroimaging

Mesh:

Year:  2020        PMID: 32990105      PMCID: PMC8190935          DOI: 10.1177/1591019920962881

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.764


  13 in total

1.  Susceptibility contrast and arterial spin labeled perfusion MRI in cerebrovascular disease.

Authors:  Ronald L Wolf; David C Alsop; Michael L McGarvey; Joseph A Maldjian; Jiongjiong Wang; John A Detre
Journal:  J Neuroimaging       Date:  2003-01       Impact factor: 2.486

2.  Diagnostic impact of transcranial color-coded real-time sonography with echo contrast agents for hyperperfusion syndrome after carotid endarterectomy.

Authors:  Shigeru Fujimoto; Kazunori Toyoda; Tooru Inoue; Yuko Hirai; Takeshi Uwatoko; Kazuhiro Kishikawa; Kotaro Yasumori; Setsuro Ibayashi; Mitsuo Iida; Yasushi Okada
Journal:  Stroke       Date:  2004-06-10       Impact factor: 7.914

3.  The reliability of color duplex ultrasound in diagnosing total carotid artery occlusion.

Authors:  A F AbuRahma; J A Pollack; P A Robinson; D Mullins
Journal:  Am J Surg       Date:  1997-08       Impact factor: 2.565

4.  Neurological injury in adults treated with extracorporeal membrane oxygenation.

Authors:  Farrah J Mateen; Rajanandini Muralidharan; Russell T Shinohara; Joseph E Parisi; Gregory J Schears; Eelco F M Wijdicks
Journal:  Arch Neurol       Date:  2011-08-08

5.  Transcranial doppler ultrasound criteria for recanalization after thrombolysis for middle cerebral artery stroke.

Authors:  W S Burgin; M Malkoff; R A Felberg; A M Demchuk; I Christou; J C Grotta; A V Alexandrov
Journal:  Stroke       Date:  2000-05       Impact factor: 7.914

6.  Transcranial Doppler sonography for detecting stenosis or occlusion of intracranial arteries in people with acute ischaemic stroke.

Authors:  Alessia Mattioni; Silvia Cenciarelli; Paolo Eusebi; Miriam Brazzelli; Tatiana Mazzoli; Massimo Del Sette; Carlo Gandolfo; Marinella Marinoni; Cinzia Finocchi; Valentina Saia; Stefano Ricci
Journal:  Cochrane Database Syst Rev       Date:  2020-02-19

7.  Transcranial Doppler is an effective method in assessing cerebral blood flow patterns during peripheral venoarterial extracorporeal membrane oxygenation.

Authors:  Michael Salna; Hirohisa Ikegami; Joshua Z Willey; Arthur R Garan; Marisa Cevasco; Christine Chan; Hiroo Takayama; Paolo C Colombo; Yoshifumi Naka; Koji Takeda
Journal:  J Card Surg       Date:  2019-05-06       Impact factor: 1.620

8.  Extracorporeal membrane oxygenation and cerebral blood flow velocity in children.

Authors:  Nicole F O'Brien; Mark W Hall
Journal:  Pediatr Crit Care Med       Date:  2013-03       Impact factor: 3.624

9.  Imaging adults on extracorporeal membrane oxygenation (ECMO).

Authors:  Steven Lee; Abhishek Chaturvedi
Journal:  Insights Imaging       Date:  2014-10-09

Review 10.  Incidence, Outcome, and Predictors of Intracranial Hemorrhage in Adult Patients on Extracorporeal Membrane Oxygenation: A Systematic and Narrative Review.

Authors:  Alexander Fletcher-Sandersjöö; Eric Peter Thelin; Jiri Bartek; Mikael Broman; Marko Sallisalmi; Adrian Elmi-Terander; Bo-Michael Bellander
Journal:  Front Neurol       Date:  2018-07-06       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.